Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Arthritis, Juvenile Idiopathic”

299 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 299 results

Early research (Phase 1)Study completedNCT04018599
What this trial is testing

Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

Who this might be right for
Rheumatoid ArthritisPolyarticular Juvenile Idiopathic ArthritisPsoriatic Arthritis+8 more
Fresenius Kabi SwissBioSim GmbH 216
Early research (Phase 1)Looking for participantsNCT06222034
What this trial is testing

Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)

Who this might be right for
Juvenile Idiopathic Arthritis
Alfasigma S.p.A. 10
Not applicableStudy completedNCT02001844
What this trial is testing

Foot Orthoses (FOs) on Pain, Quality of Life and the Gait With Children Diagnosed With JIA

Who this might be right for
Arthritis, Juvenile Rheumatoid
University of Newcastle, Australia 60
Post-approval studies (Phase 4)Study completedNCT07428551
What this trial is testing

Comparative Study of Leflunomide Plus Methotrexate Versus Methotrexate Monotherapy in Refractory Polyarticular Juvenile Idiopathic Arthritis Patients

Who this might be right for
Juvenile Idiopathic ArthritisPolyarticular Juvenile Idiopathic ArthritisRefractory Polyarticular Juvenile Idiopathic Arthritis
Bangladesh Medical University 50
Not applicableLooking for participantsNCT05925452
What this trial is testing

To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.

Who this might be right for
Active Systemic Juvenile Idiopathic Arthritis
Changchun GeneScience Pharmaceutical Co., Ltd. 221
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07138898
What this trial is testing

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

Who this might be right for
Rheumatic Disease
NYU Langone Health 80
Not applicableStudy completedNCT03769558
What this trial is testing

Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur

Who this might be right for
Juvenile Idiopathic Arthritis
Bristol-Myers Squibb 264
Not applicableLooking for participantsNCT06870045
What this trial is testing

Dynamic Gait Index as a Functional Gait Assessment Measure in Children With JIA

Who this might be right for
Juvenile Idiopathic ArthritisChildhood Rheumatic Disease
Istanbul University - Cerrahpasa 52
Not applicableUnknownNCT05217277
What this trial is testing

Clinical and Biochemical Evaluation of Dental and Periodontal Conditions in Children With Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic ArthritisGingivitisDecay, Dental
Marmara University 114
Large-scale testing (Phase 3)Study completedNCT01421069
What this trial is testing

Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis

Who this might be right for
Juvenile Idiopahtic Arthritis
Pfizer 109
Not applicableStudy completedNCT02191722
What this trial is testing

"Medikidz Explain JIA Comic Book- Hebrew"

Who this might be right for
Juvenile Idiopathic Arthritis
Rabin Medical Center 4
Testing effectiveness (Phase 2)Ended earlyNCT05710640
What this trial is testing

Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) in JIA

Who this might be right for
Juvenile Idiopathic Arthritis (JIA)
National Institute of Allergy and Infectious Diseases (NIAID) 18
Large-scale testing (Phase 3)Study completedNCT02396212
What this trial is testing

Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals 19
Large-scale testing (Phase 3)Study completedNCT00144612
What this trial is testing

Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Chugai Pharmaceutical 60
Large-scale testing (Phase 3)Study completedNCT01667471
What this trial is testing

A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis Who Completed WA19977 Core Study

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 6
Not applicableLooking for participantsNCT07065747
What this trial is testing

Quantification & Classification of Inflammatory Cells in Uveitis Using OCT

Who this might be right for
Anterior Uveitis (AU)Birdshot ChorioretinitisBehcet Disease+5 more
Oregon Health and Science University 125
Large-scale testing (Phase 3)Study completedNCT02277444
What this trial is testing

Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy

Who this might be right for
Arthritis, Juvenile
Janssen Research & Development, LLC 130
Not applicableActive Not RecruitingNCT01357668
What this trial is testing

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Bristol-Myers Squibb 800
Testing effectiveness (Phase 2)Study completedNCT00213187
What this trial is testing

PEAK Study (Physical Exercise and Activity in Kids)

Who this might be right for
Juvenile Idiopathic Arthritis
The Hospital for Sick Children 80
Large-scale testing (Phase 3)Looking for participantsNCT03773965
What this trial is testing

Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Eli Lilly and Company 190
Load More Results